In summary, our study found that MDMA promotes MALAT1 expression and inhibits the targeted downregulation of MEKK3 by miR-124, resulting in upregulation of the expression of MEKK3 and finally jointly promoting the PD process. This evidence concerns the gene MAP3K3 and Parkinson disease.